MECHEL PJSC-SPONSORED ADR (MTL) Fundamental Analysis & Valuation

NYSE:MTL • US5838406081

Current stock price

2.25 USD
-0.05 (-2.17%)
At close:
2.25 USD
0 (0%)
After Hours:

This MTL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. MTL Profitability Analysis

1.1 Basic Checks

  • MTL had positive earnings in the past year.
MTL Yearly Net Income VS EBIT VS OCF VS FCFMTL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 20B 40B 60B

1.2 Ratios

Industry RankSector Rank
ROA 31.85%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MTL Yearly ROA, ROE, ROICMTL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 0 -10 -20 -30

1.3 Margins

Industry RankSector Rank
OM 22.61%
PM (TTM) 19.51%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MTL Yearly Profit, Operating, Gross MarginsMTL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. MTL Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, MTL has less shares outstanding
  • Compared to 1 year ago, MTL has a worse debt to assets ratio.
MTL Yearly Shares OutstandingMTL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 100M 200M 300M 400M
MTL Yearly Total Debt VS Total AssetsMTL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 100B 200B 300B 400B

2.2 Solvency

  • MTL has an Altman-Z score of 0.04. This is a bad value and indicates that MTL is not financially healthy and even has some risk of bankruptcy.
  • A Debt/Equity ratio of -0.02 indicates that MTL is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity -0.02
Debt/FCF N/A
Altman-Z 0.04
ROIC/WACCN/A
WACCN/A
MTL Yearly LT Debt VS Equity VS FCFMTL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 -100B -200B

2.3 Liquidity

  • MTL has a Current Ratio of 0.26. This is a bad value and indicates that MTL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MTL has a Quick Ratio of 0.26. This is a bad value and indicates that MTL is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.26
Quick Ratio 0.11
MTL Yearly Current Assets VS Current LiabilitesMTL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 100B 200B 300B 400B 500B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. MTL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 386.40% over the past year.
  • Measured over the past years, MTL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -41.84% on average per year.
  • MTL shows a strong growth in Revenue. In the last year, the Revenue has grown by 36.22%.
  • MTL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.95% yearly.
EPS 1Y (TTM)386.4%
EPS 3Y-58.68%
EPS 5Y-41.84%
EPS Q2Q%184.7%
Revenue 1Y (TTM)36.22%
Revenue growth 3Y-3.9%
Revenue growth 5Y0.95%
Sales Q2Q%59.74%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MTL Yearly Revenue VS EstimatesMTL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 100B 200B 300B
MTL Yearly EPS VS EstimatesMTL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 -0.1 -0.2 -0.3 -0.4

More info and screens

Find the best growth stocksShow best growing peers

2

4. MTL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 1.07, which indicates a rather cheap valuation of MTL.
  • When comparing the Price/Earnings ratio of MTL to the average of the S&P500 Index (25.51), we can say MTL is valued rather cheaply.
Industry RankSector Rank
PE 1.07
Fwd PE N/A
MTL Price Earnings VS Forward Price EarningsMTL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.96
MTL Per share dataMTL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MTL Dividend Analysis

5.1 Amount

  • No dividends for MTL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

MTL Fundamentals: All Metrics, Ratios and Statistics

MECHEL PJSC-SPONSORED ADR

NYSE:MTL (2/25/2022, 8:04:00 PM)

After market: 2.25 0 (0%)

2.25

-0.05 (-2.17%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A
Earnings (Next)03-01
Inst Owners0%
Inst Owner Change-65.09%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap910.75M
Revenue(TTM)357.08B
Net Income(TTM)69.65B
Analysts44
Price Target0.13 (-94.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.07
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 3.96
EPS(TTM)2.1
EY93.33%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.69
BVpS-5.74
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 31.85%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 22.61%
PM (TTM) 19.51%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.63
Health
Industry RankSector Rank
Debt/Equity -0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.26
Quick Ratio 0.11
Altman-Z 0.04
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)386.4%
EPS 3Y-58.68%
EPS 5Y-41.84%
EPS Q2Q%184.7%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)36.22%
Revenue growth 3Y-3.9%
Revenue growth 5Y0.95%
Sales Q2Q%59.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

MECHEL PJSC-SPONSORED ADR / MTL Fundamental Analysis FAQ

What is the fundamental rating for MTL stock?

ChartMill assigns a fundamental rating of 4 / 10 to MTL.


What is the valuation status for MTL stock?

ChartMill assigns a valuation rating of 5 / 10 to MECHEL PJSC-SPONSORED ADR (MTL). This can be considered as Fairly Valued.


What is the profitability of MTL stock?

MECHEL PJSC-SPONSORED ADR (MTL) has a profitability rating of 7 / 10.


Can you provide the financial health for MTL stock?

The financial health rating of MECHEL PJSC-SPONSORED ADR (MTL) is 3 / 10.